Possible fraud dogs Unilife

The medical device maker plumetted today despite management securing an important contract, with management issues and possible fraud dogging the stock.

The Unilife Corporation (UNS) rollercoaster ride took another unexpected plunge today even as management secured an important contract with pharmaceutical giant Sanofi.

Shareholders should have been rewarded by the highly anticipated news that could generate more than $100 million in annual revenue for Unilife.

But corporate governance issues are dogging the stock, which crashed 7.8% in lunch time trade to 59 cents.


SMS Code Sent…

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device

Verify your mobile number to unlock a FREE trial

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa

Related Articles